S. Shah and A. Ratner, Trends in Invasive Pneumococcal Disease--Associated Hospitalizations, Clinical Infectious Diseases, vol.42, issue.1, pp.1-5, 2006.
DOI : 10.1086/498745

K. Robinson, W. Baughman, G. Rothrock, N. Barrett, M. Pass et al., Epidemiology of Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Infections in the United States, 1995-1998<SUBTITLE>Opportunities for Prevention in the Conjugate Vaccine Era</SUBTITLE>, JAMA, vol.285, issue.13, pp.1729-1735, 1995.
DOI : 10.1001/jama.285.13.1729

D. Angus, W. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001.
DOI : 10.1097/00003246-200107000-00002

T. Marrie and M. Shariatzadeh, Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit, Medicine, vol.86, issue.2, pp.103-111, 2007.
DOI : 10.1097/MD.0b013e3180421c16

URL : http://doi.org/10.1097/md.0b013e3180421c16

M. Levy, R. Dellinger, S. Townsend, W. Linde-zwirble, J. Marshall et al., The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis, Intensive Care Medicine, vol.299, issue.suppl, pp.222-231, 2010.
DOI : 10.1007/s00134-009-1738-3

J. Bordon, T. Wiemken, P. Peyrani, M. Paz, M. Gnoni et al., Decrease in Long-term Survival for Hospitalized Patients With Community-Acquired Pneumonia, Chest, vol.138, issue.2, pp.279-283, 2010.
DOI : 10.1378/chest.09-2702

T. File and T. Marrie, Burden of Community-Acquired Pneumonia in North American Adults, Postgraduate Medicine, vol.26, issue.44, pp.130-141, 2010.
DOI : 10.1378/chest.121.1.264

I. Martin-loeches, T. Lisboa, A. Rodriguez, C. Putensen, D. Annane et al., Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia, Intensive Care Medicine, vol.47, issue.Suppl 9A, pp.612-620, 2010.
DOI : 10.1007/s00134-009-1730-y

H. Georges, O. Leroy, C. Vandenbussche, B. Guery, S. Alfandari et al., Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia, Intensive Care Medicine, vol.25, issue.2, pp.198-206, 1999.
DOI : 10.1007/s001340050816

P. Moine, J. Vercken, S. Chevret, and P. Gajdos, Severe Community-acquired Pneumococcal Pneumonia, Scandinavian Journal of Infectious Diseases, vol.22, issue.3, pp.201-206, 1995.
DOI : 10.7326/0003-4819-115-6-428

R. Wunderink, Adjunctive Therapy in Community-Acquired Pneumonia, Seminars in Respiratory and Critical Care Medicine, vol.30, issue.02, pp.146-153, 2009.
DOI : 10.1055/s-0029-1202933

T. Van-der-poll and S. Opal, Pathogenesis, treatment, and prevention of pneumococcal pneumonia, The Lancet, vol.374, issue.9700, pp.1543-1556, 2009.
DOI : 10.1016/S0140-6736(09)61114-4

M. Niederman, L. Mandell, A. Anzueto, J. Bass, W. Broughton et al., Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

S. Ewig, M. Ruiz, J. Mensa, M. Marcos, J. Martinez et al., Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.158, issue.4, pp.1102-1108, 1998.
DOI : 10.1164/ajrccm.158.4.9803114

R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee, p.28, 1992.
DOI : 10.1378/chest.101.6.1644

G. Bernard, A. Artigas, K. Brigham, J. Carlet, K. Falke et al., The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination., American Journal of Respiratory and Critical Care Medicine, vol.149, issue.3, pp.818-824, 1994.
DOI : 10.1164/ajrccm.149.3.7509706

R. Bellomo, C. Ronco, J. Kellum, R. Mehta, and P. Palevsky, Acute renal failure definition , outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Critical Care, vol.8, issue.4, pp.204-212, 2004.
DOI : 10.1186/cc2872

L. Gall, J. Klar, J. Lemeshow, S. Saulnier, F. Alberti et al., The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group, JAMA: The Journal of the American Medical Association, vol.276, issue.10, pp.802-810, 1996.
DOI : 10.1001/jama.276.10.802

L. Gall, J. Lemeshow, S. Saulnier, and F. , A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-2963, 1993.
DOI : 10.1001/jama.1993.03510240069035

J. Nuorti, J. Butler, M. Farley, L. Harrison, A. Mcgeer et al., Cigarette Smoking and Invasive Pneumococcal Disease, New England Journal of Medicine, vol.342, issue.10, pp.681-689, 2000.
DOI : 10.1056/NEJM200003093421002

K. Mahmood, K. Eldeirawi, and M. Wahidi, Association of gender with outcomes in critically ill patients, Critical Care, vol.16, issue.3, p.92, 2012.
DOI : 10.1097/01.CCM.0000190242.24410.17

M. Angele, S. Pratschke, and I. Chaudry, Does gender influence outcomes in critically ill patients? Crit Care, p.129, 2012.

A. Rodriguez, T. Lisboa, S. Blot, I. Martin-loeches, J. Sole-violan et al., Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough, Intensive Care Medicine, vol.133, issue.3, pp.430-438, 2009.
DOI : 10.1007/s00134-008-1363-6

C. Garcia-vidal, N. Fernandez-sabe, J. Carratala, V. Diaz, R. Verdaguer et al., Early mortality in patients with community-acquired pneumonia: causes and risk factors, European Respiratory Journal, vol.32, issue.3, pp.733-739, 2008.
DOI : 10.1183/09031936.00128107

T. Marrie and D. Low, A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology ??? Results from a Canadian Multicenter Study, Canadian Respiratory Journal, vol.10, issue.7, pp.368-374, 2003.
DOI : 10.1155/2003/862856

J. Bordon, P. Peyrani, G. Brock, F. Blasi, J. Rello et al., The Presence of Pneumococcal Bacteremia Does Not Influence Clinical Outcomes in Patients With Community-Acquired Pneumonia, Chest, vol.133, issue.3, pp.618-624, 2008.
DOI : 10.1378/chest.07-1322

L. Mandell, R. Wunderink, A. Anzueto, J. Bartlett, G. Campbell et al., consensus guidelines on the management of community-acquired pneumonia in adults, Infectious Diseases Society of America Clin Infect Dis, issue.2, pp.44-71, 2007.

C. Garcia-vidal, C. Ardanuy, F. Tubau, D. Viasus, J. Dorca et al., Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes, Thorax, vol.65, issue.1, pp.77-81, 2010.
DOI : 10.1136/thx.2009.123612

URL : http://hdl.handle.net/2445/49275

P. Laterre, G. Garber, H. Levy, R. Wunderink, G. Kinasewitz et al., Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*, Critical Care Medicine, vol.33, issue.5, pp.952-961, 2005.
DOI : 10.1097/01.CCM.0000162381.24074.D7

D. Angus, Drotrecogin alfa (activated) ... a sad final fizzle to a roller-coaster party, Critical Care, vol.16, issue.1, p.107, 2012.
DOI : 10.1056/NEJMoa050935

R. Wunderink, P. Laterre, B. Francois, D. Perrotin, A. Artigas et al., Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.11, pp.1561-1568, 2011.
DOI : 10.1164/rccm.201007-1167OC

M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi et al., Hydrocortisone Infusion for Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.3, pp.242-248, 2005.
DOI : 10.1164/rccm.200406-808OC

D. Snijders, J. Daniels, C. De-graaff, T. Van-der-werf, and W. Boersma, Efficacy of Corticosteroids in Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.9, pp.975-982, 2010.
DOI : 10.1164/rccm.200905-0808OC

C. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer et al., Hydrocortisone Therapy for Patients with Septic Shock, New England Journal of Medicine, vol.358, issue.2, pp.111-124, 2008.
DOI : 10.1056/NEJMoa071366

A. Tessmer, T. Welte, P. Martus, M. Schnoor, R. Marre et al., Impact of intravenous ??-lactam/macrolide versus ??-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia, Journal of Antimicrobial Chemotherapy, vol.63, issue.5, pp.1025-1033, 2009.
DOI : 10.1093/jac/dkp088

J. Martinez, J. Horcajada, M. Almela, F. Marco, A. Soriano et al., Addition of a Macrolide to a ?????Lactam???Based Empirical Antibiotic Regimen Is Associated with Lower In???Hospital Mortality for Patients with Bacteremic Pneumococcal Pneumonia, Clinical Infectious Diseases, vol.36, issue.4, pp.389-395, 2003.
DOI : 10.1086/367541

G. Waterer, G. Somes, and R. Wunderink, Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal Pneumonia, Archives of Internal Medicine, vol.161, issue.15, pp.1837-1842, 2001.
DOI : 10.1001/archinte.161.15.1837

K. Weiss, D. Low, L. Cortes, A. Beaupre, R. Gauthier et al., Pneumonia in Adults, Canadian Respiratory Journal, vol.11, issue.8, pp.589-593, 2004.
DOI : 10.1155/2004/461392

L. Baddour, V. Yu, K. Klugman, C. Feldman, A. Ortqvist et al., Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.4, pp.440-444, 2004.
DOI : 10.1164/rccm.200311-1578OC

A. Rodriguez, A. Mendia, J. Sirvent, F. Barcenilla, M. De-la-torre-prados et al., Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*, Critical Care Medicine, vol.35, issue.6, pp.1493-1498, 2007.
DOI : 10.1097/01.CCM.0000266755.75844.05

M. Restrepo, E. Mortensen, G. Waterer, R. Wunderink, and J. Coalson, Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia, European Respiratory Journal, vol.33, issue.1, pp.153-159, 2009.
DOI : 10.1183/09031936.00054108

R. Chokshi, M. Restrepo, N. Weeratunge, C. Frei, A. Anzueto et al., Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia, European Journal of Clinical Microbiology & Infectious Diseases, vol.44, issue.Suppl 2
DOI : 10.1007/s10096-007-0307-3

R. Dwyer, A. Ortqvist, E. Aufwerber, H. Normark, B. Marrie et al., Addition of a macrolide to a ??-lactam in bacteremic pneumococcal pneumonia, European Journal of Clinical Microbiology & Infectious Diseases, vol.46, issue.Suppl 1A, pp.518-521, 2006.
DOI : 10.1007/s10096-006-0183-2

J. Aspa, O. Rajas, F. Rodriguez-de-castro, M. Huertas, L. Borderias et al., Impact of initial antibiotic choice on mortality from pneumococcal pneumonia, European Respiratory Journal, vol.27, pp.1010-1019, 2006.
DOI : 10.1183/09031936.06.00126004

D. Burgess and J. Lewis, Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia, Clinical Therapeutics, vol.22, issue.7, pp.872-878, 2000.
DOI : 10.1016/S0149-2918(00)80059-4

M. Paul, A. Nielsen, A. Gafter-gvili, E. Tacconelli, S. Andreassen et al., The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis, European Respiratory Journal, vol.30, issue.3, pp.525-531, 2007.
DOI : 10.1183/09031936.00031007

S. Harbarth, J. Garbino, J. Pugin, J. Romand, and D. Pittet, Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis, European Journal of Clinical Microbiology & Infectious Diseases, vol.40, issue.10, pp.688-690, 2005.
DOI : 10.1007/s10096-005-0018-6

S. Dowell, C. Whitney, C. Wright, C. Rose, and A. Schuchat, Seasonal Patterns of Invasive Pneumococcal Disease, Emerging Infectious Diseases, vol.9, issue.5, pp.573-579, 2003.
DOI : 10.3201/eid0905.020556

T. Talbot, K. Poehling, T. Hartert, P. Arbogast, N. Halasa et al., Seasonality of invasive pneumococcal disease: Temporal relation to documented influenza and respiratory syncytial viral circulation, The American Journal of Medicine, vol.118, issue.3, pp.285-291, 2005.
DOI : 10.1016/j.amjmed.2004.09.016

R. Pallares, J. Linares, M. Vadillo, C. Cabellos, F. Manresa et al., Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, Spain, New England Journal of Medicine, vol.333, issue.8, pp.474-480, 1995.
DOI : 10.1056/NEJM199508243330802

J. Aspa, O. Rajas, F. Rodriguez-de-castro, J. Blanquer, R. Zalacain et al., Drug???Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors, Clinical Infectious Diseases, vol.38, issue.6, pp.787-798, 2004.
DOI : 10.1086/381886

A. Kumar, D. Roberts, K. Wood, B. Light, J. Parrillo et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.1589-1596, 2006.
DOI : 10.1097/01.CCM.0000217961.75225.E9

J. Phua, K. See, Y. Chan, L. Widjaja, N. Aung et al., Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia, Thorax, vol.64, issue.7, pp.598-603, 2009.
DOI : 10.1136/thx.2009.113795

M. Lujan, M. Gallego, Y. Belmonte, D. Fontanals, J. Valles et al., Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia, European Respiratory Journal, vol.36, issue.5, pp.1073-1079, 2010.
DOI : 10.1183/09031936.00176309

J. Mira, A. Max, and P. Burgel, The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy, Critical Care, vol.12, issue.Suppl 6, p.5, 2008.
DOI : 10.1186/cc7028

M. Brouwer, J. De-gans, S. Heckenberg, A. Zwinderman, T. Van-der-poll et al., Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.9, issue.1, pp.31-44, 2009.
DOI : 10.1016/S1473-3099(08)70261-5